Literature DB >> 32865263

Grading Bleomycin-Induced Pulmonary Fibrosis in ex vivo Mouse Lungs Using Ultrasound Image Analysis.

Boran Zhou1, Juntao Shao1,2, Kyle J Schaefbauer3, Ashley M Egan4, Eva M Carmona4,3, Andrew H Limper4,3, Xiaoming Zhang.   

Abstract

OBJECTIVES: The aim of this study was to assess bleomycin-induced pulmonary fibrosis on ex vivo mouse lungs using ultrasound image grading and texture analysis.
METHODS: Excised mouse lungs were divided into 3 groups: control, mild fibrosis, and severe fibrosis based on the monitored indicators of health. B-mode ultrasound images were obtained via scanning the mouse lungs ex vivo. The surface smoothness, echo density, and angle of lesions or the lung margin were graded, and the imaging contrast, correlation, homogeneity, and entropy were assessed via texture analysis.
RESULTS: The grades of surface smoothness, echo density, and angle were statistically higher for the severe fibrosis group compared with those of the control and mild fibrosis groups (P < .05). In addition, statistically significant differences in the contrast, correlation, and homogeneity between mild and severe fibrosis groups were observed (P < .05).
CONCLUSIONS: The results obtained in this study suggest that ultrasound image grading and texture analysis are valuable and meaningful methods for assessing pulmonary fibrosis in a bleomycin mouse model.
© 2020 American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  bleomycin injury; mouse lung; pulmonary fibrosis; texture analysis; ultrasound grading

Mesh:

Substances:

Year:  2020        PMID: 32865263      PMCID: PMC8851405          DOI: 10.1002/jum.15448

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  28 in total

1.  Computerized ultrasound B-scan texture analysis of experimental diffuse parenchymal liver disease: correlation with histopathology and tissue composition.

Authors:  G Layer; I Zuna; A Lorenz; H Zerban; U Haberkorn; P Bannasch; G van Kaick; U Räth
Journal:  J Clin Ultrasound       Date:  1991-05       Impact factor: 0.910

2.  Ultrasound image texture analysis for characterizing intramuscular fat content of live beef cattle.

Authors:  N Kim; V Amin; D Wilson; G Rouse; S Udpa
Journal:  Ultrason Imaging       Date:  1998-07       Impact factor: 1.578

3.  Echographic tissue characterization in diffuse parenchymal liver disease: correlation of image structure with histology.

Authors:  U Haberkorn; I Zuna; A Lorenz; H Zerban; G Layer; G van Kaick; U Räth
Journal:  Ultrason Imaging       Date:  1990-07       Impact factor: 1.578

4.  Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study.

Authors:  D Y Lin; I S Sheen; C T Chiu; S M Lin; Y C Kuo; Y F Liaw
Journal:  J Clin Ultrasound       Date:  1993-06       Impact factor: 0.910

Review 5.  Noninvasive tools to assess liver disease.

Authors:  Paul J Clark; Keyur Patel
Journal:  Curr Opin Gastroenterol       Date:  2011-05       Impact factor: 3.287

6.  Severe liver fibrosis or cirrhosis: accuracy of US for detection--analysis of 300 cases.

Authors:  Agostino Colli; Mirella Fraquelli; Marco Andreoletti; Barbara Marino; Enrico Zuccoli; Dario Conte
Journal:  Radiology       Date:  2003-02-19       Impact factor: 11.105

Review 7.  Diagnosis and quantitation of fibrosis.

Authors:  Diarmuid S Manning; Nezam H Afdhal
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

8.  Ultrasonographic evaluation of pulmonary consolidation.

Authors:  P C Yang; K T Luh; D B Chang; C J Yu; S H Kuo; H D Wu
Journal:  Am Rev Respir Dis       Date:  1992-09

9.  Cirrhosis: diagnosis with sonographic study of the liver surface.

Authors:  A Di Lelio; C Cestari; A Lomazzi; L Beretta
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

Review 10.  Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?

Authors:  Susanne Bonekamp; Ihab Kamel; Steven Solga; Jeanne Clark
Journal:  J Hepatol       Date:  2008-11-08       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.